TARGET FOR MCAR : $15 !!!!!!!!!!!!!!!!!!!!!!
Public Analysis & Review (PAR) Announces Investment Opinion on 'Research Notes' Added To Website at www.investrend.com
NEW YORK, Sep 8, 1999 (BUSINESS WIRE) -- Nine of the eighteen fully
reporting public companies covered in the nationally acclaimed Public
Analysis & Review (PAR) program -- Corp HQ (OTCBB: COHQ), Cadapult
Graphics (OTCBB: GRFX), M&A West (OTCBB: MAWI), Medcare Technologies
(Nasdaq: MCAR), Planet City (OTCBB: PINC), Q-Seven Systems (OTCBB:
QSSY), Scottsdale Scientific (OTCBB: STDS), Virtuallender.com (OTCBB:
VLDC), and Vasogen (OTCBB: VSOGF) -- are trading significantly below
the targets recently established by independent analysts qualified in
the PAR program, according to John M. Dutton, president of Investrend
Research, administrator of the program for the nonprofit Investors
Research Institute, Inc.
Dutton, supervisory analyst for the Institute, also announced that the
organizations' website at http:www.investrend.com has introduced a
'Research Notes' section.
Dutton said this section provides a means for investment community
professionals and the public to check updates on the 18 enrolled public
companies by the 13 analysts currently in the program between quarterly
reviews, giving the public a greater immediacy of analytical data and
professional opinions.
Dutton also said that PAR is preparing to ramp up its coverage for
dozens of additional companies, and that investment community
professionals or public company executives wishing to enroll a company,
should contact him prior to next week's Board of Directors meeting for
Investrend.
The companies currently trading under their respective targets, pegged
an average of six to 18 months out, are as follows:
Corp HQ, trading at 5/8, was targeted at 2.25 in the quarterly review
by Analyst Gary Clark, Ph.D., CFA, on August 5.
Cadapult Graphics, trading at 2 3/16, was targeted at 6.25 in the
quarterly review by Analyst Jane Freedman on May 18.
M&A West, trading 5 3/16, was targeted 12 to 15 in initial report by
Analyst James Reda on July 22.
Medcare Technologies, trading at 2 3/4, was targeted at 15 by Analyst
John M. Dutton in his initial report March 13.
Planet City, trading at 3/4, received a revised target of $2 by William
Davison, Ph.D, in his quarterly update on June 10 and research notes
posted August 24.
Q-Seven Systems, trading at 2 3/8, was targeted at $10 by Analyst
William Davison, Ph.D., in his initial report August 11 and research
notes posted August 25.
Scottsdale Scientific, trading at 11/16, was targeted at 3 1/2 by
Analyst Jane Freedman in her initial report June 24.
Virtuallender.com, trading at 3 3/16, was targeted at 10 by Analyst
Gary Clark, Ph.D., CFA, in his initial report August 3.
Vasogen, trading at 2, was targeted at 2 1/2 by Analyst Randall D.
Lewis in his initial report July 27.
Analyst reports and research comments on these companies are avaialble
at www.investrend.com.
Three PAR covered companies, Starnet Communications (OTCBB: SNMM),
AlphaTrade (OTCBB: EBNK) and Boystoys (OTCBB: GRLZ), currently have
their targets on hold, awaiting further corporate developments, and
coverage of Crys-Tel Communications (OTCBB: CYSS), was recently
suspended. Up to date analyst explenations are in 'Research Notes'.
Rockport Healthcare Group (OTCBB: RPHL), a newly enrolled Company in
the PAR program, will be covered by Gerald LaKarnafeaux, CFA.
A schedule of upcoming research reports as well as recently issued
reports is posted at www.investrend.com.
Thirteen wirehouse-quality analysts have qualified in the PAR program.
Their reports are issued completely independent of both the Institute
and covered public companies. Analysts who have qualified include Joyce
Baynard, NYC, Richard Bliss, NYC, Gary N. Clark, Ph.D, CFA, Pasadena,
CA., William W. Davison, Ph.D., Fairfield, CT, John M. Dutton, Los
Angeles, J. Freedman, Miami, Gerald F. LaKarnafeaux, CFA, Ivins, UT,
Stanley Lanzet, NYC, Randall D. Lewis, Los Angeles, James F. Reda,
Marietta, GA, Darren Robinson, CFA, Toronto, ON, Harvey Robinson, CFA,
Laurel, MD and Bradley S. Wilds, CFA, NYC. |
